Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Eculizumab

EU orphan designation number: EU/3/13/1185   
Active ingredient: Eculizumab
Indication: Treatment of neuromyelitis optica
Sponsor: Alexion Europe SAS
25 boulevard de l'Amiral Bruix, F-75016 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/087/13 (2013)5284 of 05/08/2013